Delivery Order SPE2DB24D1205-SPE2DB24FCQRR

Award Date 4/19/24
Potential Completion Date 4/22/24
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,339,361 units of Lidocaine 5% Patch 30s, a pharmaceutical product. The $1,700.37 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 22, 2024. The award is not associated with a set-aside program. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $5,172.00 for the supply of 4564961123 - Lidocaine 5% Patch 30s. The contract, issued by the Defense Logistics Agency (DLA) which is part of the U.S. Department of Defense, does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 4,564,535,197 units of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 and runs through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of 4,564,097,616 units of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,604.39 firm fixed price delivery order has a completion date of March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp. is a delivery order worth $21,005.14 for the supply of 4558531687 - Lidocaine 5% Patch 30s. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $1,315.20 for the supply of 4,564,360,453 units of Lidocaine 5% Patch 30s. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the delivery of these pharmaceutical products by April 23, 2024. This contract does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,589,836 units of Lidocaine 5% Patch 30S to the Defense Logistics Agency (DLA). The delivery order contract, valued at $2,746.98, was awarded on a firm fixed price basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,811.52, is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of 4,564,389,586 units of Lidocaine 5% Patch 30S. The contract, valued at $11,378.66, was awarded by the Defense Logistics Agency (DLA), a defense agency, on April 24, 2024, with a completion date of April 25, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is the prime contractor for this firm-fixed-price delivery order contract, which is not designated as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order (DO) valued at $1,553.37 for the supply of 4,565,089,492 units of Lidocaine 5% Patch 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen, a major pharmaceutical distribution company, without the use of a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCQRR
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,340 units of Lidocaine 5% Patch 30s. The $8,290.07 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000.

Generated 7/19/24, 10:04 AM